Search

everythinglearnresearchcommunity

for

Search:↓

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Flutamide reduces hair growth better but has more side effects.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Melatonin improved mental health and metabolism in women with PCOS.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

High levels of androgens during early development may cause PCOS-like symptoms.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Certain hormone treatments can improve acne and related conditions in women.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.